CompletedNCT01921582
A Comparison of Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Binge Eating disorders
Medication studyAges 18–50Canada
Understand this study
Who was this study for?
Listed age limits: 18 years to 50 years.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateAugust 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 51
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT01921582
- Official title
Show the full official title
A Randomized Comparison of Osmotic Release Oral System Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Obese Patients With Binge Eating Disorder
Get this study by email
Recruitment & locations
CompletedToronto
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Methylphenidate.
Who was this study for?
Listed age limits: 18 years to 50 years.
